## Results

### Variation in receptor abundance drives variation in response

![**Possible effects of bivalent Fc-cytokine formats.**](./output/figureC1.svg){#fig:C1}

### Comprehensive molecular response profiling

![**B2.** (A)](./output/figureC2.svg){#fig:C2}

### Bivalent Fc-cytokine fusions have distinct cell specificity but not dynamics

![**pSTAT5 response varies in a cell type- and treatment-specific manner.** (A)](./output/figureC3.svg){#fig:C3}

### Difference in cell response is explained by a simple, multivalent binding model

![**Uncertainty propagation accurately quantifies CD25-mediated signaling variation.** (A)](./output/figureC4.svg){#fig:C4}

### Multivalent binding model also captures cell-to-cell variability

![**B5.** (A)](./output/figureC5.svg){#fig:C5}

### Multivalency provides a general strategy for enhanced binding selectivity

![**Multivalency can further improve specificity but requires coordinate affinity adjustments.** (A)](./output/figureC6.svg){#fig:C6}
